Alan Beresford

Dihydropyrancarboxamides Related to Zanamivir:  A New Series of Inhibitors of Influenza Virus Sialidases. 1. Discovery, Synthesis, Biological Activity, and Structure−Activity Relationships of 4-Guanidino- and 4-Amino-4<i>H</i>-pyran-6-carboxamides

Paul W. Smith, Steven L. Sollis, Peter D. Howes et al. · Journal of Medicinal Chemistry · 1998 · 339 citations · Full text

Greater Inhibitory Activity, New Series, Antiviral Drug +16

ADME/PK as part of a rational approach to drug discovery

Peter Eddershaw, Alan Beresford, Martin K. Bayliss · Drug Discovery Today · 2000 · 237 citations

Drug Target, Biochemistry, Medicine +4

The emerging importance of predictive ADME simulation in drug discovery

Harold E. Selick, Alan Beresford, Michael H. Tarbit · Drug Discovery Today · 2002 · 236 citations

Drug Target, Engineering, Medicine +8

Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors

Anthony A. Estrada, Xingrong Liu, Charles Baker‐Glenn et al. · Journal of Medicinal Chemistry · 2012 · 160 citations · Full text

Small Molecule Inhibitors, Broad Kinase Selectivity, Drug Target +19

The Metabolism and Pharmacokinetics of Amlodipine in Humans and Animals

D. A. Stopher, Alan Beresford, P. V. Macrae et al. · Journal of Cardiovascular Pharmacology · 1988 · 158 citations

Cf Nifedipine, New Calcium-channel Blocker, Pharmacological Study +9